Structural basis for a high affinity inhibitor bound to protein kinase MK2

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• The Ser/Thr protein kinase MAPKAP kinase 2 (MK2) is integral to inflammatory processes.
• Understanding MK2's structure is key for developing targeted anti-inflammatory therapies.

Purpose of the Study:

• To elucidate the binding mode of a high-affinity inhibitor to the kinase domain of MK2.
• To investigate the structural basis of MK2's conformational flexibility for drug design.

Main Methods:

• X-ray crystallography was employed to determine the structure of MK2 in complex with an inhibitor.
• Two distinct crystal forms were obtained through soaking and co-crystallization techniques.
• Analysis of the crystal structures revealed details of inhibitor binding and protein conformation.

Main Results:

• The first structures of MK2 complexed with a high-affinity inhibitor (IC50 8.5 nM) were obtained.
• Two crystal forms demonstrated conformational flexibility within the MK2 binding site.
• Crystal form-2 revealed MK2 trimers, with one trimer potentially modeling an intermediate state in substrate phosphorylation.

Conclusions:

• The determined structures provide a detailed view of MK2-inhibitor interactions.
• The observed conformational flexibility offers insights for structure-based drug design.
• The trimer model presents a potential mechanism for MK2's role in substrate phosphorylation.